Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2470)
All Articles published online
|
Sep 28, 2005 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Enjoji M, Morizono S, Kotoh K, Kohjima M, Miyagi Y, Yoshimoto T, Nakamuta M. Re-evaluation of antitumor effects of combination chemotherapy with interferon-α and 5-fluorouracil for advanced hepatocellular carcinoma. World J Gastroenterol 2005; 11(36): 5685-5687 [PMID: 16237765 DOI: 10.3748/wjg.v11.i36.5685] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i36/5685.htm |
| Number | Citing Articles |
| 1 |
HIROKI UEDA, HIROKO FUKUCHI, CHIGUSA TANAKA. Toxicity and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma (Review). Oncology Letters 2012; 3(2): 259 doi: 10.3892/ol.2011.469
|
| 2 |
Matthew S. Strand, Ryan C. Fields. Primary and Metastatic Liver Tumors. 2018; : 333 doi: 10.1007/978-3-319-91977-5_27
|
| 3 |
Hiroki Nishikawa, Yukio Osaki, Ryuichi Kita, Toru Kimura. Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in Japan. Cancers 2012; 4(1): 165 doi: 10.3390/cancers4010165
|
| 4 |
Tatsuya Yamashita. Current Status of Hepatocellular Carcinoma Treatment in Japan. Clinical Drug Investigation 2012; 32: 15 doi: 10.2165/1163022-S0-000000000-00000
|
| 5 |
Shimul A. Shah, Sean P. Cleary, Alice C. Wei, Ilun Yang, Bryce R. Taylor, Alan W. Hemming, Bernard Langer, David R. Grant, Paul D. Greig, Steven Gallinger. Recurrence after liver resection for hepatocellular carcinoma: Risk factors, treatment, and outcomes. Surgery 2007; 141(3): 330 doi: 10.1016/j.surg.2006.06.028
|
| 6 |
Yoon Khei Ho, Jun Yung Woo, Kin Man Loke, Lih-Wen Deng, Heng-Phon Too. Enhanced anti-tumor efficacy with multi-transgene armed mesenchymal stem cells for treating peritoneal carcinomatosis. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05278-5
|
| 7 |
Yu‐Yun SHAO, Chun‐Chieh HUANG, Po‐Chin LIANG, Zhong‐Zhe LIN. Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma. Asia-Pacific Journal of Clinical Oncology 2010; 6(2): 80 doi: 10.1111/j.1743-7563.2010.01287.x
|
| 8 |
TOMOYUKI NEMOTO, HIDETAKA MATSUDA, TAKUTO NOSAKA, YASUSHI SAITO, YOSHIHIKO OZAKI, RYOKO HAYAMA, TATSUSHI NAITO, KAZUTO TAKAHASHI, KAZUYA OFUJI, MASAHIRO OHTANI, KATSUSHI HIRAMATSU, HIROYUKI SUTO, YASUNARI NAKAMOTO. Comparison of hepatic arterial infusion chemotherapy and sorafenib in elderly patients with advanced hepatocellular carcinoma: A case series. Molecular and Clinical Oncology 2014; 2(6): 1028 doi: 10.3892/mco.2014.371
|
| 9 |
Bazarragchaa Damdinsuren, Hiroaki Nagano, Morito Monden. Combined intra‐arterial 5‐fluorouracil and subcutaneous interferon‐alpha therapy for highly advanced hepatocellular carcinoma. Hepatology Research 2007; 37(s2) doi: 10.1111/j.1872-034X.2007.00191.x
|
| 10 |
Tatsuya Yamashita. Current Status of Hepatocellular Carcinoma Treatment in Japan. Clinical Drug Investigation 2012; 32(S2): 15 doi: 10.1007/BF03265493
|